In recent years, major drugmakers like Johnson & Johnson and AbbVie have starkly increased donations to nonprofits with the power to influence legislation in favor of the pharmaceutical industry, according to Bloomberg Government.
Pharmacy
A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in punitive damages in a case accusing the drugmaker of downplaying the risks associated with its antipsychotic drug, Risperdal, according to The New York Times.
Puma Biotechnology raised the price of its breast cancer drug, Nerlynx, by 20 percent this year, according to STAT.
GlaxoSmithKline is recalling prescription-only versions of its heartburn medicine Zantac globally after the U.S. Food and Drug Administration found "unacceptable" levels of a potential carcinogen in the drug, according to Channel News Asia.
A consumer advocacy group filed a citizen's petition Oct. 8 asking the FDA to immediately withdraw Makena, a drug designed to prevent premature births, after it failed a confirmatory study.
Advertisement
MinuteClinic, CVS Health's retail medical clinic, launched telehealth programs in three more states.
An AIDS advocacy group is calling on Gilead to significantly lower the price of Descovy, its newest HIV-prevention drug approved Oct. 3.
Jim Greenwood, the CEO of the drug industry lobby Biotech Innovation Organization, will step down at the end of 2020, according to Politico.
Charlotte, N.C.-based Premier's ProvideGx program is partnering with Amphastar Pharmaceuticals to supply hospitals with seven drugs in critical shortage.
Michigan's Medicaid program might stop using its contracted, third party pharmacy benefit managers to handle prescription drug claims and price negotiations. Instead the state would manage drug coverage itself, according to a Sept. 30 proposed policy draft.